nView medical Inc. news
Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company with a spine and orthopedics focus, and nView medical, a Salt Lake City-based company developing surgical imaging and guidance systems enabled by artificial intelligence (AI
nView medical Inc. (nView) announces the 510(k) clearance of the nView s1 with navigation option by the U.S. Food and Drug Administration (FDA).
nView’s mission is to make surgery safer, faster, and consistently accurate by creating instant 3D information throughout the surgical procedure. nView s1 is an imaging system that integrate
The nView s1, nView medical’s breakthrough imaging system reached its 50th surgery. Twelve surgeons across three leading pediatric hospitals have used nView’s insta-3D™ technology on procedures ranging from spinal deformity corrections, to discectomies, periacetabular osteotomies and extremity procedures.
nView medical CEO, Cristian Atria, commented:
“To celebrate the 50th surgery milestone we gave the
Children’s National Hospital today performed the first surgical use of breakthrough medical imaging technology designed specifically for kids. The innovation, insta-3D™ imaging from company nView medical, is designed to make 3D images available in the operating room quickly and safely. The 3D images provide surgeons with better visualization, allowing them to continue improving patient care and outcomes.
nView medical, a medical imaging company with breakthrough image creation technology, is preparing to pilot its first surgical scanner: the nView s1. This week HealthTech Arkansas announced that nView was selected out of a pool of hundreds of applicants to participate in its Accelerator Program, which guarantees pilots within its network of 11 healthcare providers: Arkansas Children’s Hospital, Arkansas Heart Hospital, Arkansas Urology, Baptist Health, CHI St. Vincent,
Announced today, nView medical, a leading innovator in 3D medical imaging, and OrthoGrid Systems, Inc., a global MedTech leader offering intraoperative alignment technologies, are partnering to provide integrated solutions that increase surgical accuracy OR efficiency and improve patient outcomes
As the first step for implementation, the companies are executing a proof of concept for a periacetabular osteot
nView medical Inc. (nView) today announced the U.S. Food and Drug Administration (FDA) clearance of nView s1, the company’s first imaging system, bringing breakthrough imaging technology to surgery.
nView’s mission is to make surgery safer, faster, and consistently accurate by creating instant 3D information throughout the surgical procedure. nView s1 integrates the latest developments in low-dose x-ray imaging with intelligent imaging algorithms to provide fluoroscopic an
“Most computer assisted intervention solutions use pre-operative 3D data and/or intra-operative 2D imaging. nView medical aims at providing intraoperative low-dose 3D imaging allowing surgeo
nView medical CEO, Cristian Atria, was recently in Singapore attending a Utah trade mission led by Utah Governor Gary R. Herbert. The Utah mission focused in building relationships between Utah and Singapore, including building business partnerships, investments, sharing best practices and of course spurring import/export & trade. The delegation was composed of key business people, entrepreneurs, politicians and administrators.
nView medical was invited to participate as part of a
Earlier this month nView medical (http://www.nviewmed.com/) and the Laboratory for Computational Sensing and Robotics at Johns Hopkins University (http://lcsr.jhu.edu/) entered a joint research agreement to integrate optical technology into nView medical`s real-time surgical imaging system.
nView medical`s mission is to provide the most precise information during surgical procedures to improve accuracy, minimize